baber/WOPTO huggingface dataset:
Patent NZ-234676-A (NZ)
Title: Double glazed electromagnetic shielding panel: capacitive coupling earths internal layer
Inventor: CLARKE LESLIE THOMAS
IPC: H05K9/00
Filed: 1990-07-27
Abstract: An electromagnetic shielding panel (1, 2, 3, 4, P5) incorporates at least two electroconductive coatings (10 and 6, 7,8). In two of the panels (1,2) the coatings are carried on separate sheets of float glass (5,9), one of the coatings 10 being an anti-abrasive coating is on the outermost surface of the glass (9) in the panel arrangement, while the other coating (6,7,8) being a relatively soft abrasive-sensitive coating, e.g. silver, is on the innermost of the glass 5 in the panel arrangements. In other panel arrangements (3,4,P5) the two coatings are located on opposing sides of one glass sheet 9 and on two of the panels (3,4) a plain sheet of float glass (11) is employed to protect the soft silver coating (6,7,8). In another panel (P5) a sheet of glass (9) carrying an anti-abrasive coating (10) is employed. The panels are of the double glazed type (Fig. 1, Fig. 3, Fig. 5) and the laminated type (Fig. 2, Fig. 4). This invention utilises the enhanced capacitive coupling (C) between the two coatings (10 and 6,7, 8) to effectively earth the innermost silver coating (6,7,8) by way of the anti-abrasive coating 10 without any direct electrical connection being required to be made to the innermost coating (6,7,8).
Patent NZ-236326-A (NZ)
Title: Delayed-release oral dosage formulation comprising cimetidine with a release-delaying coating
Inventor: MENTION JACKY
IPC: A61K9/32
Filed: 1990-12-04
Abstract: Delayed-release oral dosage forms are described comprising cimetidine or a salt thereof and optionally a buffer that is capable of aiding dissolution of cimetidine in the intestine, coated with a release-delaying substance comprising a coating agent such as Eudragit<R> L 30 D.
Patent NZ-245869-A (NZ)
Title: Azaindole derivatives, preparation and pharmaceutical compositions thereof
Inventor: FESTAL DIDIER
IPC: A61P43/00
Filed: 1993-02-09
Abstract: These compounds correspond to the formula, <IMAGE>  in which,   one of the groups X1 to X4 represents nitrogen and the others a CH radical, R1 and R2 represent H, halogen, alkyl, hydroxymethyl, alkyloxymethyl, dialkylaminoalkyl, dialkylaminoalkyloxymethyl, carboxyl, ethyl carboxylate, piperidino, alkenyl, cycloalkyl, cycloalkenyl, alkylthio, benzyl, phenyl, thiophene or pyridine, optionally substituted, R3 and R4 represent H, halogen, alkyl, cycloalkyl, alkoxy or alkylthio, R5 and R6 denote H, alkyl, alkenyl, cycloalkyl, cycloalkenyl, alkoxyalkyl, alkylthioalkyl, or together form alkylene or alkyleneoxyalkylene chains, R7 denotes H, alkyl or cycloalkyl, one of the R5 to R7 radicals can also denote optionally substituted phenyl or benzyl, R8 represents H, alkyl, cycloalkyl, phenyl or benzyl, optionally substituted, R9 denotes optionally substituted phenyl, naphthyl or heterocyclyl,   and their tautomeric forms, processes for their preparation and application as hypolipidaemic and anti-atheromatous medicaments.
Patent NZ-247033-A (NZ)
Title: Drive for spin washer: agitator shaft bearings are motor rotor bearings
Inventor: WILLIAMS JOHN JULIAN AUBREY
IPC: H02K1/27
Filed: 1988-09-28
Abstract: An electric motor (30) stator (31) and rotor (51 to 55) are made by holding magnetic elements (32, 53) thereof in position in dies (25; 66 to 69) and injecting a plastics material into the dies to provide bearing carrier mountings (27, 51) substantially concentric with the pole faces (33) of the stator (31) and poles (53) of the rotor. The motor is completed by providing a bearing (21) in the stator bearing carrier mounting (27) and a shaft (13) in the rotor bearing carrier mounting (51), the shaft running also in a further bearing mounting tube (8). The motor and drive so made is mounted to drive an agitator (7) and spin tub (4) of a laundry machine (1). <IMAGE>
Patent NZ-261190-A (NZ)
Title: Assaying for functional activity of a blood coagulation component involved in the protein c anticoagulant system (protein c, activated protein c, protein s or anticoagulant factor v)
Inventor: DAHLBACK BJORN
IPC: C12Q1/68
Filed: 1994-01-28
Abstract: Methods are disclosed for determining, in a sample derived from a human, the functional activity of a component of the human blood coagulation system, which activity can be correlated to conversion of a substrate specific for activated Protein C (APC), by measuring in an assay medium containing the sample and a substrate for APC, the conversion of the substrate by APC and correlating the conversion to the functional activity of the component. When the component is anticoagulant Factor V, at least one of exogenous APC, Protein S or an inhibitor of Protein S activity is added to the medium. When the component is Protein C, APC, or Protein S, exogenous anticoagulant Factor V or an inhibitor of anticoagulant activity of Factor V is added to the medium. Methods are also disclosed for diagnosing a blood coagulation/anticoagulation disorder or for determining a predisposition thereto in a human by determining anticoagulant Factor V activity in an assay medium containing a sample derived from the human.
Patent NZ-276444-A (NZ)
Title: 3-aminoethyl indoles substituted in position-5 by a moiety containing a 4-phenylpiperazin-1-yl radical
Inventor: HALAZY SERGE
IPC: A61P25/30
Filed: 1994-11-17
Abstract: PCT No. PCT/FR94/01343 Sec. 371 Date May 17, 1996 Sec. 102(e) Date May 17, 1996 PCT Filed Nov. 17, 1994 PCT Pub. No. WO95/14004 PCT Pub. Date May 26, 1995   <IMAGE>  (I)   <IMAGE>   Novel indole-derived azylpiperazines of general formula (I), wherein, inter alia, R1 is NH2 or NO2, R'1, R2, R'2, R3 and R4 are H, Z is -C- and X is 0. Methods for preparing such derivatives and the therapeutical uses thereof are also disclosed.
Patent NZ-285448-A (NZ)
Title: Fused indan derivatives; compounds and pharmaceutical compositions
Inventor: OKAZAKI SHINJI
IPC: A61K31/44
Filed: 1995-05-18
Abstract: A fused indan derivative represented by general formula (1), a pharmaceutically acceptable salt thereof, and an antitumor drug, wherein ring A represents an optionally substituted benzene or naphtalene ring, or a benzene ring having a lower alkylenedioxy group; ring B represents a benzene ring which may be substituted or has a lower alkylenedioxy group; Y represents -N=CR- or -CR=N-; R represents -NR1R2, -OR3 or an optionally substituted nitrogenous heterocyclic group; R1 and R2 are the same or different from each other and each represents hydrogen, phenyl, an optionally substituted nitrogenous heterocyclic group, or a lower alkyl group which may be substituted by at least one substituent selected from the group consisting of optionally substituted amino, lower alkoxy, phenyl, a nitrogenous heterocyclic group, an amine oxide group substituted by lower alkyl, and hydroxy; and R3 represents lower alkyl which may be substituted by substituted amino, provided the case where R represents an optionally substituted nitrogenous heterocyclic group and rings A and B represent each an unsubstituted benzene ring, is excluded. <CHEM>
Patent NZ-286402-A (NZ)
Title: Multifocus, concentric annular ring contact lens for astigmatic presbyopes
Inventor: ROFFMAN JEFFREY H
IPC: G02C7/04
Filed: 1996-04-18
Abstract: Combined multifocal toric lens designs are disclosed which combine a correction for astigmatism, either corneal or lenticular, with a correction for presbyopia. One of the front and back surfaces of the lens defines a toric surface for an astigmatic optical correction, and one of the front and back surfaces, which can be the same surface or the opposite surface, defines a multifocal surface for a presbyopic optical correction, to provide visual acuity for astigmatic presbyopes. Embodiments are disclosed wherein one surface of the lens design has a combined concentric annular ring, multifocal toric surface, and the other surface of the lens design has a spherical or aspherical surface. In other embodiments, one surface of the lens design has a toric surface for a toric correction, and the other surface of the lens design has a multifocal surface to provide a presbyopic correction, which may include concentric annular ring multifocal lens designs, or other presbyopic lens designs which contain more than one spherical or aspherical power such as aspheres, segments, progressive aspheres, diffractive, birefringent or other concentrics. <IMAGE>
Patent NZ-325798-A (NZ)
Title: Micropropagation of shoots, rooted shoots, or seedlings, by complete immersion in oxygenated liquid medium
Inventor: EDWARDS GLYN ALYN
IPC: A01H1/04
Filed: 1996-12-16
Abstract: Shoots, rooted shoots, and seedlings of a woody plant are micropropagated by completely immersing them in an oxygenated liquid medium.  The liquid medium can be oxygenated by passing oxygen or air through it.   The woody plant can be a gymnosperm or dicotyledenous angiosperm used for wood pulp, fuel, or timber; a tree, shrub or bush that produces fruit or nuts; or an ornamental tree or shrub.  This process is also useful for reducing microbial contamination of shoots, rooted shoots, or seedlings.  A process for the selection of genetically modified plant  material is described, where the genetically modified plant material is micropropagated according to the method described above.
Patent NZ-333003-A (NZ)
Title: Veneer reeling, veneer carried on spaced belts pressed against take-up reel
Inventor: KOIKE MASARU
IPC: B65H29/00
Filed: 1998-11-25
Abstract: A veneer reeling apparatus includes a veneer take-up reel 35 driven by contact with touch rollers 5.  The veneer is conveyed towards the take-up reel 35 by conveyors 4, the rollers 5 working in gaps between the conveyors 4.  There are two laterally spaced groups of conveyors.  Each conveyor 4 is pressed into contact with the take-up reel by plate 28, which is actuated by pneumatic cylinder 25.  The cylinder 25 can press the belts against the reel 35 with one of two forces, a first force, and a smaller second force which may be zero.  The first and second forces by be applied alternately to the two groups of conveyors.  The forces may be changed regularly when the belts have moved a predetermined distance, for example 500mm.
Patent NZ-501661-A (NZ)
Title: PTFE lubricated valve for aerosol container
Inventor: BURT PETER COLLIN WESTON
IPC: B65D83/14
Filed: 1998-06-25
Abstract: There is provided a valve for an aerosol container for dispensing a suspension or solution of a substance in a liquid propellant contained therein as shown in Fig. 1. The valve comprises a valve body (1) defining an aperture, a seal (9) mounted at the aperture, and a valve stem (7) having a dispensing passage (11), the valve stem (7) being slideably moveable through the seal (9) such that in a first position the valve is closed to prevent the substance to be dispensed from entering the dispensing passage (11) and in a second position the valve is open to allow the substance to be dispensed through the dispensing passage (11). The valve stem (7) is made from a fluorine-containing polymer free from any silicone material.
Patent NZ-503049-A (NZ)
Title: Remote document scanning and transmission to central location
Inventor: BALLARD CLAUDIO R
IPC: G06Q20/00
Filed: 1998-08-26
Abstract: A  system for remote data acquisition and  centralized processing  and  storage.  The system provides  support  for the  processing of documents and electronic data  associated with   different  applications  including  sale,   business, banking  and  general  consumer  transactions.   The  system retrieves  transaction  data such as  credit  card  receipts checks  in  either electronic or paper form at one  or  more remote   locations,   encrypts  the  data,   transmits   the encrypted  data to a central location, transforms  the  data to  a  usable  form,  performs  identification  verification using   signature   data  and  biometric   data,   generates informative   reports  from  the  data  and  transmits   the informative reports to the remote location(s).  The  network architecture  facilitates secure communication  between  the remote  location(s) and the central processing facility.   A dynamic   address   assignment   algorithm   performs   load balancing  among the system's servers for faster performance and  higher utilization.  A partitioning scheme improves the error correction process.
Patent NZ-504298-A (NZ)
Title: 2,3-methano-amino acid compounds for treating serine protease disorders
Inventor: VERBEUREN TONY
IPC: C07D221/04
Filed: 2000-05-02
Abstract: 2,3 -methano-amino acid compounds of the formula shown, to a process for their preparation, to the pharmaceutical compositions containing them and their use as trypsin-related serine protease inhibitors. R1 represents a C3-8cycloalkyl group, an optionally substituted phenyl group or a linear or branched C1-6alkyl group optionally substituted by one or more identical or different groups selected from halogen, C3-8cycloalkyl and optionally substituted phenyl; R2 represents an amino group, an amidino group optionally substituted by one or more identical or different groups selected from linear or branched C1-6alkyl and hydroxy, a guanidino group optionally substituted by a linear or branched C1-6alkyl group, or an isothioureido group optionally substituted by a linear or branched C1-6alkyl group; Ar represents an aryl group or a monocyclic nitrogen-containing heteroaryl group; X1 represents a hydroxy group, an amino group or an -NHR3 group, R3 represents a propargyl group, an iminomethyl group, a linear or branched C1-6alkylsulphonyl group, a linear or branched arylC1-6alkylsulphonyl group, a -CONR'3R"3 group or a linear or branched C1-6alkyl group optionally substituted by a -CO2R'3 group, a -CONR'3R"3 group, a heterocyclic group, an aminosulphonyl group, an aryl group, or a heteroaryl group, * R'3 and R"3, which may be identical or different, each represents a hydrogen atom, or a linear or branched C1-6alkylsulphonyl group, an aryl group, a linear or branched C1-6alkyl group (optionally substituted by a carboxy group, a linear or branched C1-6alkoxycarbonyl group or a carbamoyl group) or form, with the nitrogen atom carrying them; a heterocyclic group;
Patent NZ-504657-A (NZ)
Title: Reacting 8-halogeno-quinolonecarboxylic acid derivatives with alkanols or benzyl alcohol
Inventor: GEHRING REINHOLD
IPC: C07D215/16
Filed: 1998-11-12
Abstract: The 8-methoxy-quinoline (quinolone) carboxylic acids are antibiotics that have potent antibacterial action against Gram-negative and Gram-positive bacteria.  The process for preparation of the 3-quinoline carboxylic acid derivatives offers considerable advantages in terms of product yield, reaction time and work-up. Preparation of 7-(cyclic amino)-6-fluoro-1,4-dihydro-8-alkoxy-4-oxo-3-quinoline-carboxylic acid derivatives involves reacting 8-halo analogues with an alkali metal tertiary alkoxide in an ether solvent in presence of an alkanol or benzyl alcohol.
Patent NZ-508969-A (NZ)
Title: Pesticidal emulsion containing levamisole in the aqueous phase and a macrocyclic lactone anthelmintic in the organic phase
Inventor: SORENSEN ALLEN PAUL
IPC: A01N43/52
Filed: 1999-06-04
Abstract: A storage stable partitioned biocidal composition comprises: in an organic phase, a macrocyclic lactone (first biocide) soluble in the organic phase and in an aqueous phase at acid pH, a second biocide at least partly soluble in the aqueous phase.  The first biocide is unstable at the acid pH.
Patent NZ-508994-A (NZ)
Title: Neurotrophic factors
Inventor: HANSEN CLAUS
IPC: A61P25/16
Filed: 1999-07-05
Abstract: An isolated nucleic acid encoding a Glial cell-line derived neurotrophic factor (GDNF) called Neublastin comprising a sequence selected from: Seq ID: 1 listed in the disclosure; A nucleic acid sequence comprising an open reading frame which encodes a polypeptide with at least 90% homology to AA---1-AA105 of Seq ID: 2 listed in the disclosure. Also disclosed are an expression vector containing said nucleic acid sequence, cells transformed with said expression vector, polypeptides produced by said cell, use of said polypeptide in the manufacture of a medicament for treating neurodegenerative disease involving lesioned and traumatic neurons.
Patent NZ-509681-A (NZ)
Title: Building block for an inclined wall made from permeable or porous concrete
Inventor: MASON BRETT KERRY
IPC: E02B3/14
Filed: 1999-07-27
Abstract: A plurality of building blocks (1) form a retaining wall (300), which may be curved, with respective side edges (6, 7) providing pivot points and a stepped base (5) of an upper block (1) being positionable on the upper surface (4) of a lower block (1). The gaps between the blocks (1), and their porosity if made from permeable concrete, can avoid hydrostatic build up behind the wall (300).
Patent NZ-515606-A (NZ)
Title: Contact support for cycle safety device
Inventor: GAUTIER GERARD
IPC: B62J6/04
Filed: 2001-03-22
Abstract: A contact support suitable for mounting on a cycle brake control cable, the support comprising: a first portion which is fixed relative to the cycle frame, said fixed portion having a first contact surface; a second portion which is movable relative to the cycle frame, and suitable for being secured to the cable, said moving portion presenting a second contact surface; the support comprising connection means between the fixed portion and the moving portion, said connection means being suitable for being deformed elastically between: an extreme relaxed state for the support in which the contact surfaces are spaced apart from each other; and a tensioned state for the support in which the contact surfaces press against each other, the connection means then being elastically deformed.
Patent NZ-515779-A (NZ)
Title: 3alpha-hydroxy-3beta methoxymethyl-21-heterocycle substituted steroids with anesthetic activity
Inventor: HOGENKAMP DERK L
IPC: C07J31/00
Filed: 2000-04-28
Abstract: Compounds of formula (I), wherein: R1 is H or methyl, R2 is 5á- or 5â-H, R3 is an optionally substituted N-attached heteroaryl group or a group -X-R4, R4 is an optionally substituted carbon-attached heteroaryl group, and X is O, S or NH. The compounds are used in the manufacture of medicaments for the alleviating or preventing insomnia or inducing anesthesia in an animal subject.
Patent NZ-516477-A (NZ)
Title: Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders
Inventor: ROUGEON FRANCOIS
IPC: A61K38/08
Filed: 2000-06-22
Abstract: Use of a peptide comprising an amino acid sequence selected from the amino acid sequences shown in SEQ ID No 1, SEQ ID No 2, SEQ ID No 3 and SEQ ID No4, or an allelic variant thereof, or a peptidomimetic thereof, for the preparation of a medicament for reducing or eliminating symptoms of a DSM-III disorder in a mammal having a DAM-III disorder.
Patent NZ-517860-A (NZ)
Title: Account system processing for a remote computer by a seperate database system using different format
Inventor: LANGMAID RICK ROLAND
IPC: G06Q40/00
Filed: 2000-09-15
Abstract: An  account processing method, executed by an  account system,   including   receiving   account   data   over    a communications  network,  the  account  data   having   been extracted   in   a  first  predetermined  format   from   an accounting software package of a remote computer  system  of a  client,  processing the account data  for  storage  in  a database  system in a second predetermined format and  in  a predetermined form based on parameters for the  client,  and generating  customer account information, such as  statement data,  from  the  account data in the  database  system  for respective customers of the client is disclosed.
Patent NZ-524571-A (NZ)
Title: Improvements in or relating to a meeting planning aid and/or a method of planning
Inventor: HERMAN DAVID LAWRENCE
IPC: G06Q10/10
Filed: 2003-03-05
Abstract: An aid to idea processing comprises a viewable information carrier contained in an electronic storage device in association with an electronic data processing means. The carrier is viewable on a screen associated with and controlled by the electronic data processing means and has areas capable of receiving relevant notations of a process directed to an objective so as to represent the essentially dynamic relationships in a structural manner.
Patent NZ-530450-A (NZ)
Title: Phenoxy carboxylic acid compounds and compositions for delivering active agents
Inventor: LEONE-BAY ANDREA
IPC: C07C229/18
Filed: 2000-11-06
Abstract: Described are phenoxy carboxylic acid compounds of formula 1, for which the substituents are defined herein. The compounds are used in the manufacture of pharmaceutical compositions for delivering active agents by way of oral, intracolonic, pulmonary, and other routes of administration. (62) Divided out of 517964
Patent NZ-530461-A (NZ)
Title: Noise attenuator
Inventor: KHAN ANWA
IPC: E04B5/12
Filed: 2002-06-19
Abstract: A noise attenuating member (12) has a channel (24) for receiving a timber batten (13). A flooring (14) may be affixed to the batten (13). The noise attenuating member acts as a cushion between the batten (13) and a substrate such as a joist (11) or a concrete slab. Noise attenuating holes and retaining flanges (25) may optionally be provided.
Patent NZ-534724-A (NZ)
Title: Fertiliser product with plant nutrient fine powder coating
Inventor: GREEN KERRY
IPC: C05G3/80
Filed: 2003-02-25
Abstract: A method of preparing and coating fertiliser pellets is disclosed. Fertiliser, seed or other agronomic carrier materials are added to a blender. Powdered micronutrients are added to the blend (at any time in the process) at rates up to but not exceeding 1% of the total blend. The resulting blend is mixed for a minimum of 20 seconds resulting in an even distribution (coating) of the total blend. The blend is then packaged into bags, spreaders or trucks and stored or applied to the field. Seed or fertiliser is augured or moved via conveyors or other means into seeding equipment or a blender. The finished product is then applied to the field or stored for later applications.
Patent NZ-536765-A (NZ)
Title: Automated condensing unit test apparatus and associated methods
Inventor: ATCHISON ANTHONY E
IPC: G01M13/00
Filed: 2004-11-24
Abstract: A test module 10 is connectable to the suction line 26 of a condensing unit 12 charged with refrigerant and is electrically connectable to the unit and is useable to automatically test for proper operation of the unit without having to connect an external test coil to the unit or place pressurized nitrogen in the unit. After the module is connected to the unit the compressor is started to operate the unit in an open loop mode with no refrigerant recirculation, the liquid line 28 being capped. The module monitors the suction line pressure. If the sensed pressure reaches a predetermined magnitude within a predetermined time after compressor start-up, the module outputs a first signal indicating proper condensing unit operation. If the predetermined pressure is not timely attained, a second signal is generated to indicate test failure. In the case of a heat pump condensing unit the module tests for proper heating, cooling, and defrost operation.
Patent NZ-540941-A (NZ)
Title: Process for producing amorphous form of eplerenone exhibiting enhanced dissolution rate
Inventor: BARTON KATHLEEN
Filed: 2000-12-04
Abstract: A process for preparing amorphous eplerenone is disclosed, wherein the process comprises: (a) a step of forming a dispersion of eplerenone in water; (b) a step of flash freezing the dispersion; and (c) a step of freeze drying the frozen dispersion to form amorphous eplerenone. Amorphous eplerenone is useful as an intermediate in the preparation of crystalline Form H and crystalline Form L of eplerenone. In addition, it is believed that amorphous eplerenone possesses a different dissolution rate compared to its crystalline Forms and, where amorphous eplerenone is present in a pharmaceutical composition and where dissolution of eplerenone in the gastrointestinal tract is the rate-controlling step for delivery of the eplerenone to the target cells, such amorphous eplerenone can provide different bioavailability relative to Form H and Form L.